N-Isopropyl-2,3,N-trimethyl-2-butylamin | 91014-13-0

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-Isopropyl-2,3,N-trimethyl-2-butylamin
• 英文别名: N,2,3-trimethyl-N-propan-2-ylbutan-2-amine
• CAS: 91014-13-0
• 化学式: C₁₀H₂₃N
• 分子量: 157.299
• InChiKey: CQRDHSYXIVBRGS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• Tetradentate Platinum And Palladium Complex Emitters Containing Phenyl-Pyrazole And Its Analogues
  申请人：Li Jian

  公开号：US20150194616A1

  公开（公告）日：2015-07-09

  A phosphorescent emitter or delayed fluorescent and phosphorescent emitters represented by Formula 1 or Formula II, where M is platiunum or palladium.

  一个磷光发射器或延迟荧光和磷光发射器，由公式1或公式II表示，其中M是铂或钯。
• METAL-ASSISTED DELAYED FLUORESCENT EMITTERS CONTAINING TRIDENTATE LIGANDS
  申请人：Arizona Board of Regents on behalf of Arizona State University

  公开号：US20160043331A1

  公开（公告）日：2016-02-11

  Tridentate platinum, palladium, and gold complexes of Formulas A-I and A-II and tridentate iridium and rhodium compounds of Formulas B-I, B-II, and B-III suitable for delayed fluorescent and phosphorescent or phosphorescent emitters in display and lighting applications.

  公式A-I和A-II的三齿铂、钯和金配合物以及公式B-I、B-II和B-III的三齿铱和铑化合物，适用于延迟荧光和磷光或磷光发射器，在显示和照明应用中使用。
• ANTIVIRAL COMPOUNDS
  申请人：Guo Hongyan

  公开号：US20120157404A1

  公开（公告）日：2012-06-21

  The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

  该发明涉及抗病毒化合物、含有这些化合物的组合物以及包括给予这些化合物的治疗方法，还涉及用于制备这些化合物的过程和中间体。
• AZO-SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS
  申请人：Kwong Cecil D.

  公开号：US20110286964A1

  公开（公告）日：2011-11-24

  The present invention provides compounds of Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R 1 , X, Y, Z, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 18 , R 19 , and n is selected independently and as defined herein. Compositions comprising such compounds are also provided. The compounds of the invention are effective as inhibitors of HCV, and are useful, alone and together with other therapeutic agents, in treating or preventing dieases or disorders such as viral infections and virus-related disorders.

  本发明提供了式(I)的化合物：（将在论文中以纸质形式出现的化学式插入此处）（I）及其互变异构体、异构体和酯类，以及所述化合物的药学上可接受的盐、溶剂化物和前药，其中每个R、R1、X、Y、Z、R2、R3、R4、R5、R6、R7、R8、R9、R18、R19和n均是独立选择并如所定义。还提供了包含此类化合物的组合物。本发明的化合物是HCV抑制剂，可用于治疗或预防病毒感染和与病毒相关的疾病或障碍，单独或与其他治疗剂一起使用。
• IL-12 MODULATORY COMPOUNDS
  申请人：Sun Lijun

  公开号：US20100256132A1

  公开（公告）日：2010-10-07

  The invention relates to heterocyclic compounds, compositions including the compounds and methods of using and methods of making thereof. The compounds (and compositions) are useful, inter alia, in modulating IL-12 production and processes mediated by IL-12.

  本发明涉及杂环化合物、包括该化合物的组合物以及使用和制备该化合物的方法。该化合物（和组合物）在调节IL-12产生和由IL-12介导的过程中具有实用性。